NCT06279975 Pupillometric Evaluation in Patients Declared Brain Dead - a Prospective Quality Control Study
| NCT ID | NCT06279975 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Basel, Switzerland |
| Condition | Brain Death |
| Study Type | OBSERVATIONAL |
| Enrollment | 50 participants |
| Start Date | 2023-12-18 |
| Primary Completion | 2029-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 50 participants in total. It began in 2023-12-18 with a primary completion date of 2029-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of the study is to verify the reliability of the current purely clinical examination of the pupils (without the support of a pupillometer) in the context of clinically suspected brain death, compared to the results of a non-invasive, automated, and highly precise monocular pupillometric examination.
Eligibility Criteria
Inclusion Criteria: * Suspected diagnosis of brain death * Brain death diagnostic procedures planned * Treated at the intensive care unit at the University Hospital Basel (USB)
Contact & Investigator
Raoul Sutter, Prof.
PRINCIPAL INVESTIGATOR
University Hospital, Basel, Switzerland
Frequently Asked Questions
Who can join the NCT06279975 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Brain Death. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06279975 currently recruiting?
Yes, NCT06279975 is actively recruiting participants. Contact the research team at raoul.sutter@usb.ch for enrollment information.
Where is the NCT06279975 trial being conducted?
This trial is being conducted at Basel, Switzerland, Basel, Switzerland.
Who is sponsoring the NCT06279975 clinical trial?
NCT06279975 is sponsored by University Hospital, Basel, Switzerland. The principal investigator is Raoul Sutter, Prof. at University Hospital, Basel, Switzerland. The trial plans to enroll 50 participants.